;

Home >>

Global Inactivated Vaccines Market Report 2020 by Key Players Types Applications Countries Market Size Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Published: Sep-2020 | Format: PDF | Maia Research | Number of pages: 114 | Code: MRS - 774123

The Inactivated Vaccines market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Inactivated Vaccines market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Inactivated Vaccines market. The report focuses on well-known providers in the global Inactivated Vaccines industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Inactivated Vaccines Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Inactivated Vaccines market covered in Chapter 4:
Johnson & Johnson
GlaxoSmithKline
Emergent BioSolutions, Inc
Merck & Co
Sanofi Pasteur
Serum Institute
CSL Limited
MedImmune, LLC
India Pvt. Ltd. (India)
Pfizer
Astellas Pharma Inc

In Chapter 11 and 13.3, on the basis of types, the Inactivated Vaccines market from 2015 to 2026 is primarily split into:
Pneumococcal
Influenza
HPV
Hepatitis
Rotavirus
DTP
Polio
MMR

In Chapter 12 and 13.4, on the basis of applications, the Inactivated Vaccines market from 2015 to 2026 covers:
Pediatric
Adult

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2026
Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Inactivated Vaccines Market Share by Type (2020-2026)
1.5.2 Pneumococcal
1.5.3 Influenza
1.5.4 HPV
1.5.5 Hepatitis
1.5.6 Rotavirus
1.5.7 DTP
1.5.8 Polio
1.5.9 MMR
1.6 Market by Application
1.6.1 Global Inactivated Vaccines Market Share by Application (2020-2026)
1.6.2 Pediatric
1.6.3 Adult
1.7 Inactivated Vaccines Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Inactivated Vaccines Industry Development

2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19

3 Value Chain of Inactivated Vaccines Market
3.1 Value Chain Status
3.2 Inactivated Vaccines Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Inactivated Vaccines
3.2.3 Labor Cost of Inactivated Vaccines
3.2.3.1 Labor Cost of Inactivated Vaccines Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19

4 Players Profiles
4.1 Johnson & Johnson
4.1.1 Johnson & Johnson Basic Information
4.1.2 Inactivated Vaccines Product Profiles, Application and Specification
4.1.3 Johnson & Johnson Inactivated Vaccines Market Performance (2015-2020)
4.1.4 Johnson & Johnson Business Overview
4.2 GlaxoSmithKline
4.2.1 GlaxoSmithKline Basic Information
4.2.2 Inactivated Vaccines Product Profiles, Application and Specification
4.2.3 GlaxoSmithKline Inactivated Vaccines Market Performance (2015-2020)
4.2.4 GlaxoSmithKline Business Overview
4.3 Emergent BioSolutions, Inc
4.3.1 Emergent BioSolutions, Inc Basic Information
4.3.2 Inactivated Vaccines Product Profiles, Application and Specification
4.3.3 Emergent BioSolutions, Inc Inactivated Vaccines Market Performance (2015-2020)
4.3.4 Emergent BioSolutions, Inc Business Overview
4.4 Merck & Co
4.4.1 Merck & Co Basic Information
4.4.2 Inactivated Vaccines Product Profiles, Application and Specification
4.4.3 Merck & Co Inactivated Vaccines Market Performance (2015-2020)
4.4.4 Merck & Co Business Overview
4.5 Sanofi Pasteur
4.5.1 Sanofi Pasteur Basic Information
4.5.2 Inactivated Vaccines Product Profiles, Application and Specification
4.5.3 Sanofi Pasteur Inactivated Vaccines Market Performance (2015-2020)
4.5.4 Sanofi Pasteur Business Overview
4.6 Serum Institute
4.6.1 Serum Institute Basic Information
4.6.2 Inactivated Vaccines Product Profiles, Application and Specification
4.6.3 Serum Institute Inactivated Vaccines Market Performance (2015-2020)
4.6.4 Serum Institute Business Overview
4.7 CSL Limited
4.7.1 CSL Limited Basic Information
4.7.2 Inactivated Vaccines Product Profiles, Application and Specification
4.7.3 CSL Limited Inactivated Vaccines Market Performance (2015-2020)
4.7.4 CSL Limited Business Overview
4.8 MedImmune, LLC
4.8.1 MedImmune, LLC Basic Information
4.8.2 Inactivated Vaccines Product Profiles, Application and Specification
4.8.3 MedImmune, LLC Inactivated Vaccines Market Performance (2015-2020)
4.8.4 MedImmune, LLC Business Overview
4.9 India Pvt. Ltd. (India)
4.9.1 India Pvt. Ltd. (India) Basic Information
4.9.2 Inactivated Vaccines Product Profiles, Application and Specification
4.9.3 India Pvt. Ltd. (India) Inactivated Vaccines Market Performance (2015-2020)
4.9.4 India Pvt. Ltd. (India) Business Overview
4.10 Pfizer
4.10.1 Pfizer Basic Information
4.10.2 Inactivated Vaccines Product Profiles, Application and Specification
4.10.3 Pfizer Inactivated Vaccines Market Performance (2015-2020)
4.10.4 Pfizer Business Overview
4.11 Astellas Pharma Inc
4.11.1 Astellas Pharma Inc Basic Information
4.11.2 Inactivated Vaccines Product Profiles, Application and Specification
4.11.3 Astellas Pharma Inc Inactivated Vaccines Market Performance (2015-2020)
4.11.4 Astellas Pharma Inc Business Overview

5 Global Inactivated Vaccines Market Analysis by Regions
5.1 Global Inactivated Vaccines Sales, Revenue and Market Share by Regions
5.1.1 Global Inactivated Vaccines Sales by Regions (2015-2020)
5.1.2 Global Inactivated Vaccines Revenue by Regions (2015-2020)
5.2 North America Inactivated Vaccines Sales and Growth Rate (2015-2020)
5.3 Europe Inactivated Vaccines Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific Inactivated Vaccines Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa Inactivated Vaccines Sales and Growth Rate (2015-2020)
5.6 South America Inactivated Vaccines Sales and Growth Rate (2015-2020)

6 North America Inactivated Vaccines Market Analysis by Countries
6.1 North America Inactivated Vaccines Sales, Revenue and Market Share by Countries
6.1.1 North America Inactivated Vaccines Sales by Countries (2015-2020)
6.1.2 North America Inactivated Vaccines Revenue by Countries (2015-2020)
6.1.3 North America Inactivated Vaccines Market Under COVID-19
6.2 United States Inactivated Vaccines Sales and Growth Rate (2015-2020)
6.2.1 United States Inactivated Vaccines Market Under COVID-19
6.3 Canada Inactivated Vaccines Sales and Growth Rate (2015-2020)
6.4 Mexico Inactivated Vaccines Sales and Growth Rate (2015-2020)

7 Europe Inactivated Vaccines Market Analysis by Countries
7.1 Europe Inactivated Vaccines Sales, Revenue and Market Share by Countries
7.1.1 Europe Inactivated Vaccines Sales by Countries (2015-2020)
7.1.2 Europe Inactivated Vaccines Revenue by Countries (2015-2020)
7.1.3 Europe Inactivated Vaccines Market Under COVID-19
7.2 Germany Inactivated Vaccines Sales and Growth Rate (2015-2020)
7.2.1 Germany Inactivated Vaccines Market Under COVID-19
7.3 UK Inactivated Vaccines Sales and Growth Rate (2015-2020)
7.3.1 UK Inactivated Vaccines Market Under COVID-19
7.4 France Inactivated Vaccines Sales and Growth Rate (2015-2020)
7.4.1 France Inactivated Vaccines Market Under COVID-19
7.5 Italy Inactivated Vaccines Sales and Growth Rate (2015-2020)
7.5.1 Italy Inactivated Vaccines Market Under COVID-19
7.6 Spain Inactivated Vaccines Sales and Growth Rate (2015-2020)
7.6.1 Spain Inactivated Vaccines Market Under COVID-19
7.7 Russia Inactivated Vaccines Sales and Growth Rate (2015-2020)
7.7.1 Russia Inactivated Vaccines Market Under COVID-19

8 Asia-Pacific Inactivated Vaccines Market Analysis by Countries
8.1 Asia-Pacific Inactivated Vaccines Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Inactivated Vaccines Sales by Countries (2015-2020)
8.1.2 Asia-Pacific Inactivated Vaccines Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific Inactivated Vaccines Market Under COVID-19
8.2 China Inactivated Vaccines Sales and Growth Rate (2015-2020)
8.2.1 China Inactivated Vaccines Market Under COVID-19
8.3 Japan Inactivated Vaccines Sales and Growth Rate (2015-2020)
8.3.1 Japan Inactivated Vaccines Market Under COVID-19
8.4 South Korea Inactivated Vaccines Sales and Growth Rate (2015-2020)
8.4.1 South Korea Inactivated Vaccines Market Under COVID-19
8.5 Australia Inactivated Vaccines Sales and Growth Rate (2015-2020)
8.6 India Inactivated Vaccines Sales and Growth Rate (2015-2020)
8.6.1 India Inactivated Vaccines Market Under COVID-19
8.7 Southeast Asia Inactivated Vaccines Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia Inactivated Vaccines Market Under COVID-19

9 Middle East and Africa Inactivated Vaccines Market Analysis by Countries
9.1 Middle East and Africa Inactivated Vaccines Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Inactivated Vaccines Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Inactivated Vaccines Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa Inactivated Vaccines Market Under COVID-19
9.2 Saudi Arabia Inactivated Vaccines Sales and Growth Rate (2015-2020)
9.3 UAE Inactivated Vaccines Sales and Growth Rate (2015-2020)
9.4 Egypt Inactivated Vaccines Sales and Growth Rate (2015-2020)
9.5 Nigeria Inactivated Vaccines Sales and Growth Rate (2015-2020)
9.6 South Africa Inactivated Vaccines Sales and Growth Rate (2015-2020)

10 South America Inactivated Vaccines Market Analysis by Countries
10.1 South America Inactivated Vaccines Sales, Revenue and Market Share by Countries
10.1.1 South America Inactivated Vaccines Sales by Countries (2015-2020)
10.1.2 South America Inactivated Vaccines Revenue by Countries (2015-2020)
10.1.3 South America Inactivated Vaccines Market Under COVID-19
10.2 Brazil Inactivated Vaccines Sales and Growth Rate (2015-2020)
10.2.1 Brazil Inactivated Vaccines Market Under COVID-19
10.3 Argentina Inactivated Vaccines Sales and Growth Rate (2015-2020)
10.4 Columbia Inactivated Vaccines Sales and Growth Rate (2015-2020)
10.5 Chile Inactivated Vaccines Sales and Growth Rate (2015-2020)

11 Global Inactivated Vaccines Market Segment by Types
11.1 Global Inactivated Vaccines Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global Inactivated Vaccines Sales and Market Share by Types (2015-2020)
11.1.2 Global Inactivated Vaccines Revenue and Market Share by Types (2015-2020)
11.2 Pneumococcal Sales and Price (2015-2020)
11.3 Influenza Sales and Price (2015-2020)
11.4 HPV Sales and Price (2015-2020)
11.5 Hepatitis Sales and Price (2015-2020)
11.6 Rotavirus Sales and Price (2015-2020)
11.7 DTP Sales and Price (2015-2020)
11.8 Polio Sales and Price (2015-2020)
11.9 MMR Sales and Price (2015-2020)

12 Global Inactivated Vaccines Market Segment by Applications
12.1 Global Inactivated Vaccines Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global Inactivated Vaccines Sales and Market Share by Applications (2015-2020)
12.1.2 Global Inactivated Vaccines Revenue and Market Share by Applications (2015-2020)
12.2 Pediatric Sales, Revenue and Growth Rate (2015-2020)
12.3 Adult Sales, Revenue and Growth Rate (2015-2020)

13 Inactivated Vaccines Market Forecast by Regions (2020-2026)
13.1 Global Inactivated Vaccines Sales, Revenue and Growth Rate (2020-2026)
13.2 Inactivated Vaccines Market Forecast by Regions (2020-2026)
13.2.1 North America Inactivated Vaccines Market Forecast (2020-2026)
13.2.2 Europe Inactivated Vaccines Market Forecast (2020-2026)
13.2.3 Asia-Pacific Inactivated Vaccines Market Forecast (2020-2026)
13.2.4 Middle East and Africa Inactivated Vaccines Market Forecast (2020-2026)
13.2.5 South America Inactivated Vaccines Market Forecast (2020-2026)
13.3 Inactivated Vaccines Market Forecast by Types (2020-2026)
13.4 Inactivated Vaccines Market Forecast by Applications (2020-2026)
13.5 Inactivated Vaccines Market Forecast Under COVID-19

14 Appendix
14.1 Methodology
14.2 Research Data Source


                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)3400 View Pricing